Bone and Cancer
Bone and Cancer
Bone and CancerBone and Cancer Foundation, PO Box 287452 Bone and Cancer New York, NY 10128-0025  
Toll Free: 888 862-0999 Bone and Cancer Email:  
Bone and Cancer

Clinical Trials

Tavist (clemastine fumarate)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.


Approval Status:

Approved March 2001

Specific Treatments:

Cold and Allergy

General Information

Tavist Allergy/Sinus/Headache, an over-the-counter medication, has been approved for the temporary relief of symptoms associated with hay fever, allergic rhinitis, and the common cold. These may include, sinus congestion and pressure, runny nose and sneezing, itchy throat, and itchy, watery eyes. Tavist Allergy/Sinus/Headache is the only over-the-counter medication to combine the antihistamine clemastine fumarate with a nasal decongestant and pain reliever.

Side Effects

General adverse events associated with the use of an analgesic, antihistamine, decongestant combination medication may include (but are not limited to) the following:

  • Drowsiness
  • Nausea
  • Stomach pain

Mechanism of Action

Tavist Allergy/Sinus/Headache contains the analgesic acetaminophen, the antihistamine clemastine fumarate, and the decongestant pseudoephedrine hydrochloride.

Additional Information

For additional information on Tavist Allergy/Sinus/Headache, please visit Novartis Consumer Products.

 How To Order Publications:

Information About

Clinical Trials



















  Copyright 2011 - The Bone and Cancer Foundation